About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Prostatic Cancer Versus Androgen Deficiency | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT02235142

Prostatic Cancer Versus Androgen Deficiency

Open study to make a comparison between hypogonadism and euogonadism patients regarding the severity of prostate cancer. The purpose of this study is to determine the importance of the relationship be...

Lead sponsor: Hopital Foch•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Hopital Foch

Age

18 - No limit years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•Male patients over than 18 years of age, with localized, stage I or II prostate cancer, not receiving local treatment (radiation, phototherapy, thermotherapy,…) or hormonal therapy, showing indication of radical prostatectomy.

Exclusion Criteria

•Absence of radical prostatectomy indication
•Patient received local or hormonal therapy prior to surgery
•Patients already enrolled in other clinical study incompatible with the study
•Patients on a treatment which can affect hormonal level (Prednisone, Ketoconazole, Abiraterone, Finasteride, Dutasteride)

Related studies

RECRUITINGPhase 1/2

A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer

NCT04633252 · Cancer Of Prostate, Prostate Neoplasms

RECRUITINGPhase 2

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

NCT07072728 · Adjustment Disorder, Adjustment Disorder With Anxious Mood, and more

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

NCT03354416 · Prostatic Cancer, Prostatic Neoplams, and more

RECRUITINGPhase 1

Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

NCT04887935 · Prostate Cancer, Cancer of Prostate

Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer

NCT05600400 · Prostate Cancer, Cancer of Prostate, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 20, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment1,614

Start dateJun 2013

Last updatedJan 20, 2022

Condition

Cancer of Prostate

Locations shown

Clinique Saint Augustin

Bordeaux

Hôpitaux Civils de Colmar

Colmar

Hôpital Henri Mondor

Créteil

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 20, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions